PRELIMINARY PROGRAM VI GEINO SYMPOSIUM 2014 Innovations in brain tumors treatment Hotel Rafael Atocha (Madrid), 27th & 28th November 2014 27th NOVEMBER 2014 15:00-15:05h WELCOME 15:05-16:50h SESSION I: LOW GRADE GLIOMA 15:10-15:30h Surgery 15:30-15:50h Molecular profiling of low grade gliomas Controversy 15:50-16:10h Chemotherapy should be part of the adjuvant treatment of lowgrade glioma 16:10-16:30h Radiotherapy is the optimal adjuvant treatment in low-grade glioma 16:30-16:50h Discussion 16:50-17:15h COFFEE BREAK 17:15-19:00h SESSION II: TARGET THERAPY IN NON GLIOMA BRAIN TUMORS 17:20-17:40h Meduloblastoma 17:40-18:00h BM in lung cancer 18:00-18:20h BM in breast cancer 18:20-18:40h BM IN melanoma 18:40-19:00h Discussion 19:00-21:00h GEINO GENERAL ASSEMBLY 21:00h WELCOME COCKTAIL TECHNICAL SECRETARIAT MFAR Secretari Coloma nº64-68. Entlo. 5º, Esc. B 08024 Barcelona [email protected] PRELIMINARY PROGRAM VI GEINO SYMPOSIUM 2014 Innovations in brain tumors treatment Hotel Rafael Atocha (Madrid), 27th & 28th November 2014 28th NOVEMBER 2014 08:15-10:40h SESSION III. RECURRENT GLIOBLASTOMA 08:20-08:40h Diagnosis of progression and response by radiological methods of image 08:40-09:00h GEINOFOTE: safety and activity analysis of the use of fotemustine in different schedules in progressive high-grade glioma in Spain 09:00-09:30h Bevacizumab plus lomustine in recurrent glioblastoma 09:30-10:00h Randomized phase II trial AVAREG with bevacizumab or fotemustine in recurrent GBM 10:00-10:20 Access to antiogenic therapy on gliomas 10:20-10:45h Discussion 10:45-11:15h COFFEE BREAK 11:15-13:00h SESSION IV. NOVEL THERAPIES EXPERIENCES 11:15-11:45h Novo TTF Therapy for recurrent GBM (New real-life evidence on efficacy and tolerability from the PRiDE patient registry) & Novo TTF + temozolomide + radiotherapy in newly diagnosed GBM (preliminaty results from EF14 trial) 11:45-12:05h Antiangiogenic drugs in bulky glioblastoma after surgery 12:05-12:35h Immunotherapy of glioma: from basic concepts to real clinical perspectives? 12:35-12:55h Rindopemimut (CDX-110) in glioblastoma multiform (GBM) 12:55-13:20h Discussion 13:20-13:25h GEINO GRANT AWARD 2014 13:25-14:50h SESSION V. NOVEL THERAPIES TRIALS 13:30-13:45h BKM 120 + chemotherapy in relapsed GBM 13:45-14:00h PARP inhibitors + temozolomide in brain tumors 14:00-14:15h Crizotinib plus temozolomide and radiotherapy patients with newly glioblastoma 14:15-14:30h Cannabinoids as anticancer agents in brain therapy 14:30-14:50h Discussion 14:50h CLOSING REMARKS 15:00h CLOSING COCKTAIL TECHNICAL SECRETARIAT MFAR Secretari Coloma nº64-68. Entlo. 5º, Esc. B 08024 Barcelona [email protected]